Retinal ganglion cell (RGC) death is the penultimate consequence of optic neuropathies such as glaucoma. Over the last two decades, the molecular pathology associated with this process has been intensively studied, and much of this work has relied on acute models of optic nerve damage in rodents, such as axotomy or controlled optic nerve crush. This research has yielded numerous important findings that have helped piece together what happens in damaged and dying RGCs. The majority of this work, however, has been limited to evaluating early retinal effects over the course of 2 to 4 weeks.
